Twelve-Dose Drug Regimen Now Also an Option for Preventing Tuberculosis in Children and Adolescents

被引：2
|
作者：
Marais, Ben J. [1 ,2 ]
机构：
[1] Childrens Hosp, Westmead, NSW 2145, Australia
[2] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia
来源：
JAMA PEDIATRICS | 2015年 / 169卷 / 03期
关键词：
D O I：
10.1001/jamapediatrics.2014.3157
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：208 / 210
页数：4
相关论文
共 49 条
  • [1] Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan
    Sun, Hsin-Yun
    Huang, Yi-Wen
    Huang, Wei-Chang
    Chang, Lih-Yu
    Chan, Pei-Chun
    Chuang, Yu-Chung
    Ruan, Sheng-Yuan
    Wang, Jann-Yuan
    Wang, Jann-Tay
    [J]. TUBERCULOSIS, 2018, 111 : 121 - 126
  • [2] Treatment for Preventing Tuberculosis in Children and Adolescents A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid
    Villarino, M. Elsa
    Scott, Nigel A.
    Weis, Stephen E.
    Weiner, Marc
    Conde, Marcus B.
    Jones, Brenda
    Nachman, Sharon
    Oliveira, Ricardo
    Moro, Ruth N.
    Shang, Nong
    Goldberg, Stefan V.
    Sterling, Timothy R.
    [J]. JAMA PEDIATRICS, 2015, 169 (03) : 247 - 255
  • [3] New Perspectives in the ITP Treatment Romiplostim now also approved for Children and Adolescents
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (03) : 148 - 150
  • [4] Treatment for Preventing Tuberculosis in Children and Adolescents: A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid (vol 169, pg 247, 2015)
    Villarino, M. E.
    Scott, N. A.
    Weis, S. E.
    [J]. JAMA PEDIATRICS, 2015, 169 (09) : 878 - 878
  • [5] Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin
    Moulding, TS
    Le, HQ
    Rikleen, D
    Davidson, P
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (06) : 743 - 748
  • [6] European guidance on drug-resistant tuberculosis in children and adolescents
    Groschel, Matthias I.
    Seddon, James A.
    Prabowo, Satria A.
    Migliori, Giovanni B.
    Graham, Stephen M.
    van den Boom, Martin
    Dara, Masoud
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2020, 4 (01): : 9 - 11
  • [7] Influenza Prophylaxis in Children: Could a Single Dose of One Drug Be an Option?
    Munoz, Flor M.
    Bernstein, Henry H.
    [J]. PEDIATRICS, 2016, 138 (06)
  • [8] Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China
    Zhang, ZhenZhen
    Cheng, ZhenLi
    Liu, QuanBo
    Shang, TingTing
    Jiang, Li
    Fu, Zhou
    Zhu, Kun
    Wang, Xiao
    Chen, Juan
    Xu, HongMei
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 21 : 375 - 379
  • [9] Higher adverse drug reactions but better completion rate of twelve-dose weekly rifapentine plus isoniazid comparing with nine-month daily isoniazid for latent tuberculosis infection among patients under maintenance dialysis
    Lin, Shu-Yung
    Wang, Ping-Huai
    Feng, Jia-Yih
    Shu, Chin-Chung
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival
    Verma, Priyanka
    Jain, Sandeep
    Kapoor, Gauri
    Tripathi, Rupal
    Sharma, Payal
    Doval, Dinesh Chandra
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : E466 - E471
12345